34TH ECNP CONGRESS HYBRID, 2-5 OCTOBER 2021, LISBON The ECNP Congress is Europe’s largest meeting in applied and translational neuroscience. Annually it brings together between 4,000 and 6,000 psychiatrists, neuroscientists, neurologists and psychologists from around the world to discuss the latest developments in the science and treatment of disorders of the brain.

ECNP

ECNP is an independent scientific association dedicated to the science and treatment of disorders of the brain. It is the largest non-institutional supporter of applied and translational neuroscience research and education in Europe. 35TH ECNP CONGRESS HYBRID, 15-18 OCTOBER 2022, VIENNA The ECNP Congress is Europe’s largest meeting in applied and translational neuroscience. Annually it brings together between 4,000 and 6,000 psychiatrists, neuroscientists, neurologists and psychologists from around the world to discuss the latest developments

in the

ECNP SCHOOL OF NEUROPSYCHOPHARMACOLOGY VIRTUAL ECNP has taken the decision to go virtual with the ECNP School of Neuropsychopharmacology in June 2021. This means that there will be no meeting in Oxford, and all content will be delivered online via required pre-recorded lectures from Friday 25 June to Tuesday 29 June 2021 and live sessions with faculty and peers from Wednesday 30 June

to

REGISTRATION

Registration. The 34th ECNP Congress 2021 is hybrid! Now you can join us in-person in Lisbon, Portugal, or follow the livestreamed congress programme online. Before entering the Registration Portal you will be asked to either login with your personal My ECNP account or create your ECNP account first. Group registration works on a voucher base. ABSTRACT SUBMISSION FOR POSTER PRESENTERS Abstract submission for poster presenters. It is no longer possible to submit your abstract. The deadline was 18 May 2021. It was also possible to submit a non-standard abstract.For example clinical cases, literature reviews and research proposals. NEUROSCIENCE-BASED NOMENCLATURE (NBN) The NbN is a publication and a digital application of psychiatric medications classified by their pharmacology and mode of action. The NbN is updated yearly, equipping clinicians with the latest insights in neuroscience in a way that can be applied to their treatment of patients on a daily basis. To move from a disease-based classification

(e.g

A CASE-BASED APPROACH TO EARLY INTERVENTION IN SCHIZOPHRENIA 3 TARGET AUDIENCE This activity is intended for an international audience of non-US psychiatrists, and neurologists. LEARNING OBJECTIVES Upon completion of this activity, participants will: MYASTHENIA GRAVIS: CO-MORBID PSYCHIATRIC DISORDERS AND USE c c Myasthenia Gravis: co-morbid psychiatric disorders and use of psychotropic medication C. Machado;L. Monteiro; B Almeida; C. Fragoeiro* Psychiatry Residents, Magalhães Lemos Hospital, Porto, Portugal Poster number . P.5.d.004 The authors declare no conflicts

ofinterest

ASSESSMENT OF IMPULSIVITY WITH SELF-REPORT SCALES AND ÇağrıÖğüt1, Koray Başar1. 1Hacettepe University Faculty of Medicine, Department of Psychiatry, Ankara, Turkey. kbasar@hacettepe.edu.tr INTRODUCTION Impulsivity is a multidimentional construct involving diverse neuropsychological and neurobiological

processes.

34TH ECNP CONGRESS HYBRID, 2-5 OCTOBER 2021, LISBON The ECNP Congress is Europe’s largest meeting in applied and translational neuroscience. Annually it brings together between 4,000 and 6,000 psychiatrists, neuroscientists, neurologists and psychologists from around the world to discuss the latest developments in the science and treatment of disorders of the brain.

ECNP

ECNP is an independent scientific association dedicated to the science and treatment of disorders of the brain. It is the largest non-institutional supporter of applied and translational neuroscience research and education in Europe. 35TH ECNP CONGRESS HYBRID, 15-18 OCTOBER 2022, VIENNA The ECNP Congress is Europe’s largest meeting in applied and translational neuroscience. Annually it brings together between 4,000 and 6,000 psychiatrists, neuroscientists, neurologists and psychologists from around the world to discuss the latest developments

in the

ECNP SCHOOL OF NEUROPSYCHOPHARMACOLOGY VIRTUAL ECNP has taken the decision to go virtual with the ECNP School of Neuropsychopharmacology in June 2021. This means that there will be no meeting in Oxford, and all content will be delivered online via required pre-recorded lectures from Friday 25 June to Tuesday 29 June 2021 and live sessions with faculty and peers from Wednesday 30 June

to

REGISTRATION

Registration. The 34th ECNP Congress 2021 is hybrid! Now you can join us in-person in Lisbon, Portugal, or follow the livestreamed congress programme online. Before entering the Registration Portal you will be asked to either login with your personal My ECNP account or create your ECNP account first. Group registration works on a voucher base. ABSTRACT SUBMISSION FOR POSTER PRESENTERS Abstract submission for poster presenters. It is no longer possible to submit your abstract. The deadline was 18 May 2021. It was also possible to submit a non-standard abstract.For example clinical cases, literature reviews and research proposals. NEUROSCIENCE-BASED NOMENCLATURE (NBN) The NbN is a publication and a digital application of psychiatric medications classified by their pharmacology and mode of action. The NbN is updated yearly, equipping clinicians with the latest insights in neuroscience in a way that can be applied to their treatment of patients on a daily basis. To move from a disease-based classification

(e.g

A CASE-BASED APPROACH TO EARLY INTERVENTION IN SCHIZOPHRENIA 3 TARGET AUDIENCE This activity is intended for an international audience of non-US psychiatrists, and neurologists. LEARNING OBJECTIVES Upon completion of this activity, participants will: MYASTHENIA GRAVIS: CO-MORBID PSYCHIATRIC DISORDERS AND USE c c Myasthenia Gravis: co-morbid psychiatric disorders and use of psychotropic medication C. Machado;L. Monteiro; B Almeida; C. Fragoeiro* Psychiatry Residents, Magalhães Lemos Hospital, Porto, Portugal Poster number . P.5.d.004 The authors declare no conflicts

ofinterest

ASSESSMENT OF IMPULSIVITY WITH SELF-REPORT SCALES AND ÇağrıÖğüt1, Koray Başar1. 1Hacettepe University Faculty of Medicine, Department of Psychiatry, Ankara, Turkey. kbasar@hacettepe.edu.tr INTRODUCTION Impulsivity is a multidimentional construct involving diverse neuropsychological and neurobiological

processes.

ECNP CONGRESSES

ECNP Congresses 34 th ECNP Congress Hybrid, 2-5 October 2021, Lisbon, Portugal The annual ECNP Congress is Europe’s largest meeting in applied and translational neuroscience. Held every autumn, the ECNP Congress brings together psychiatrists, neuroscientists, neurologists and psychologists from around the world to discuss the latest developments in the science and treatment of brain disorders. PROGRAMME ECNP WORKSHOP VIRTUAL 2021 Programme of the ECNP Workshop for Early Career Scientists in Europe

Virtual 2021

THE ECNP OFFICE

The ECNP Office The ECNP Office is charged with supporting the Executive Committee and implementing its directives. It coordinates member activities and administers, organises and publishes all ECNP’s programmes, initiatives and resources, as well as serving as the central contact point for information about and communication with

ECNP.

THE HYBRID FORMAT AND WHAT IT MEANS FOR YOU For those who are able to join us in-person Lisbon, the hybrid format will allow you to: Participate in the full range of scientific sessions and symposia. Interact face-to-face with speakers, clinical experts and research leaders. Participate actively in ‘Love your

brain’,

AGENDA - ECNP

ECNP Workshop for Early Career Scientists in Europe, Nice, France. 20-21 March. ECNP New Frontiers Meeting, Nice, France. 27 March - 1 April. ECNP School of Child and Adolescent Neuropsychopharmacology, Venice, Italy. 26 June - 1 July. ECNP School of Neuropsychopharmacology, Oxford, United Kingdom. 15-18 October. NEUROSCIENCE-BASED NOMENCLATURE (NBN) The NbN is a publication and a digital application of psychiatric medications classified by their pharmacology and mode of action. The NbN is updated yearly, equipping clinicians with the latest insights in neuroscience in a way that can be applied to their treatment of patients on a daily basis. To move from a disease-based classification

(e.g

PREVIOUS ECNP FELLOWSHIP AWARD WINNERS 2000: Nitsan Kozlovsky: Israel : Stefan Leucht: Germany : Vallo Matto: Estonia : Marianne Müller: Germany : Lukas Pezawas: Austria : 1999:

Irina Antonijevic

ECNP INDUSTRY MANUAL ECNP Industry Manual 34th ECNP Congress Hybrid, 2-5 October 2021, Lisbon, Portugal 4 The legal entity organising the congress is Stichting 34th ECNP Congress, hereafter called ECNP, a foundation incorporated under Dutch law, registered office Daltonlaan 400, 3584

BK Utrecht, The

PROGRAMME SPOTLIGHT: INTERVIEW WITH RAY DOLAN ON HOW WE Ray Dolan is the Mary Kinross Professor of Neuropsychiatry and Director of the Max Planck-UCL Centre for Computational Psychiatry and Ageing. He is a Fellow of the Royal Society (FRS). ADDICTION IS A BRAIN DISEASE, AND IT MATTERS ALAN I DOI: 10.1126/science.278.5335.45 Science 278, 45 (1997); Alan I. Leshner Addiction Is a Brain Disease, and It Matters This copy is for your personal, non-commercial use only. ECNPCONGRESSESNEW FRONTIERS IN DIGITAL HEALTHSCHOOLSSEMINARSWORKSHOP NEUROPSYCHOPHARMACOLOGY ECNP is an independent scientific association dedicated to the science and treatment of disorders of the brain. It is the largest non-institutional supporter of applied and translational neuroscience research and education in Europe. 34TH ECNP CONGRESS HYBRID, 2-5 OCTOBER 2021, LISBON The ECNP Congress is Europe’s largest meeting in applied and translational neuroscience. Annually it brings together between 4,000 and 6,000 psychiatrists, neuroscientists, neurologists and psychologists from around the world to discuss the latest developments in the science and treatment of disorders of the brain. 35TH ECNP CONGRESS HYBRID, 15-18 OCTOBER 2022, VIENNA The ECNP Congress is Europe’s largest meeting in applied and translational neuroscience. Annually it brings together between 4,000 and 6,000 psychiatrists, neuroscientists, neurologists and psychologists from around the world to discuss the latest developments

in the

ECNP CONGRESSES

ECNP Congresses 34 th ECNP Congress Hybrid, 2-5 October 2021, Lisbon, Portugal The annual ECNP Congress is Europe’s largest meeting in applied and translational neuroscience. Held every autumn, the ECNP Congress brings together psychiatrists, neuroscientists, neurologists and psychologists from around the world to discuss the latest developments in the science and treatment of brain disorders. THE HYBRID FORMAT AND WHAT IT MEANS FOR YOU For those who are able to join us in-person Lisbon, the hybrid format will allow you to: Participate in the full range of scientific sessions and symposia. Interact face-to-face with speakers, clinical experts and research leaders. Participate actively in ‘Love your

brain’,

ECNP SCHOOL OF NEUROPSYCHOPHARMACOLOGY VIRTUAL ECNP has taken the decision to go virtual with the ECNP School of Neuropsychopharmacology in June 2021. This means that there will be no meeting in Oxford, and all content will be delivered online via required pre-recorded lectures from Friday 25 June to Tuesday 29 June 2021 and live sessions with faculty and peers from Wednesday 30 June

to

ABSTRACT SUBMISSION FOR POSTER PRESENTERS Abstract submission for poster presenters. It is no longer possible to submit your abstract. The deadline was 18 May 2021. It was also possible to submit a non-standard abstract.For example clinical cases, literature reviews and research proposals.

REGISTRATION

Registration. The 34th ECNP Congress 2021 is hybrid! Now you can join us in-person in Lisbon, Portugal, or follow the livestreamed congress programme online. Before entering the Registration Portal you will be asked to either login with your personal My ECNP account or create your ECNP account first. Group registration works on a voucher base. MYASTHENIA GRAVIS: CO-MORBID PSYCHIATRIC DISORDERS AND USE c c Myasthenia Gravis: co-morbid psychiatric disorders and use of psychotropic medication C. Machado;L. Monteiro; B Almeida; C. Fragoeiro* Psychiatry Residents, Magalhães Lemos Hospital, Porto, Portugal Poster number . P.5.d.004 The authors declare no conflicts

ofinterest

ASSESSMENT OF IMPULSIVITY WITH SELF-REPORT SCALES AND ÇağrıÖğüt1, Koray Başar1. 1Hacettepe University Faculty of Medicine, Department of Psychiatry, Ankara, Turkey. kbasar@hacettepe.edu.tr INTRODUCTION Impulsivity is a multidimentional construct involving diverse neuropsychological and neurobiological

processes.

ECNPCONGRESSESNEW FRONTIERS IN DIGITAL HEALTHSCHOOLSSEMINARSWORKSHOP NEUROPSYCHOPHARMACOLOGY ECNP is an independent scientific association dedicated to the science and treatment of disorders of the brain. It is the largest non-institutional supporter of applied and translational neuroscience research and education in Europe. 34TH ECNP CONGRESS HYBRID, 2-5 OCTOBER 2021, LISBON The ECNP Congress is Europe’s largest meeting in applied and translational neuroscience. Annually it brings together between 4,000 and 6,000 psychiatrists, neuroscientists, neurologists and psychologists from around the world to discuss the latest developments in the science and treatment of disorders of the brain. 35TH ECNP CONGRESS HYBRID, 15-18 OCTOBER 2022, VIENNA The ECNP Congress is Europe’s largest meeting in applied and translational neuroscience. Annually it brings together between 4,000 and 6,000 psychiatrists, neuroscientists, neurologists and psychologists from around the world to discuss the latest developments

in the

ECNP CONGRESSES

ECNP Congresses 34 th ECNP Congress Hybrid, 2-5 October 2021, Lisbon, Portugal The annual ECNP Congress is Europe’s largest meeting in applied and translational neuroscience. Held every autumn, the ECNP Congress brings together psychiatrists, neuroscientists, neurologists and psychologists from around the world to discuss the latest developments in the science and treatment of brain disorders. THE HYBRID FORMAT AND WHAT IT MEANS FOR YOU For those who are able to join us in-person Lisbon, the hybrid format will allow you to: Participate in the full range of scientific sessions and symposia. Interact face-to-face with speakers, clinical experts and research leaders. Participate actively in ‘Love your

brain’,

ECNP SCHOOL OF NEUROPSYCHOPHARMACOLOGY VIRTUAL ECNP has taken the decision to go virtual with the ECNP School of Neuropsychopharmacology in June 2021. This means that there will be no meeting in Oxford, and all content will be delivered online via required pre-recorded lectures from Friday 25 June to Tuesday 29 June 2021 and live sessions with faculty and peers from Wednesday 30 June

to

ABSTRACT SUBMISSION FOR POSTER PRESENTERS Abstract submission for poster presenters. It is no longer possible to submit your abstract. The deadline was 18 May 2021. It was also possible to submit a non-standard abstract.For example clinical cases, literature reviews and research proposals.

REGISTRATION

Registration. The 34th ECNP Congress 2021 is hybrid! Now you can join us in-person in Lisbon, Portugal, or follow the livestreamed congress programme online. Before entering the Registration Portal you will be asked to either login with your personal My ECNP account or create your ECNP account first. Group registration works on a voucher base. MYASTHENIA GRAVIS: CO-MORBID PSYCHIATRIC DISORDERS AND USE c c Myasthenia Gravis: co-morbid psychiatric disorders and use of psychotropic medication C. Machado;L. Monteiro; B Almeida; C. Fragoeiro* Psychiatry Residents, Magalhães Lemos Hospital, Porto, Portugal Poster number . P.5.d.004 The authors declare no conflicts

ofinterest

ASSESSMENT OF IMPULSIVITY WITH SELF-REPORT SCALES AND ÇağrıÖğüt1, Koray Başar1. 1Hacettepe University Faculty of Medicine, Department of Psychiatry, Ankara, Turkey. kbasar@hacettepe.edu.tr INTRODUCTION Impulsivity is a multidimentional construct involving diverse neuropsychological and neurobiological

processes.

WINNERS ECNP EXCELLENCE AWARDS 2020 Winners ECNP Excellence Awards 2020. Neuroimaging evidence for increased neurite density in patients with bipolar disorder taking lithium: a replication study. Metabolic predictors for mortality among clozapine–treated schizophrenia patients. An Israeli nationwide

longitudinal study.

PROGRAMME ECNP WORKSHOP VIRTUAL 2021 Programme of the ECNP Workshop for Early Career Scientists in Europe

Virtual 2021

THE HYBRID FORMAT AND WHAT IT MEANS FOR YOU For those who are able to join us in-person Lisbon, the hybrid format will allow you to: Participate in the full range of scientific sessions and symposia. Interact face-to-face with speakers, clinical experts and research leaders. Participate actively in ‘Love your

brain’,

AGENDA - ECNP

ECNP Workshop for Early Career Scientists in Europe, Nice, France. 20-21 March. ECNP New Frontiers Meeting, Nice, France. 27 March - 1 April. ECNP School of Child and Adolescent Neuropsychopharmacology, Venice, Italy. 26 June - 1 July. ECNP School of Neuropsychopharmacology, Oxford, United Kingdom. 15-18 October.

ECNP SCHOOLS

The ECNP Schools have been established to encourage excellence in future leaders in clinical neuropsychopharmacology by propagating best practices during a week-long course, in that way contributing to the continuing improvement of the field’s high standards of practice. Per ECNP School, a maximum of 50 early career psychiatrists are

accepted. 1.

PREVIOUS ECNP FELLOWSHIP AWARD WINNERS 2000: Nitsan Kozlovsky: Israel : Stefan Leucht: Germany : Vallo Matto: Estonia : Marianne Müller: Germany : Lukas Pezawas: Austria : 1999:

Irina Antonijevic

NEUROSCIENCE-BASED NOMENCLATURE (NBN) The NbN is a publication and a digital application of psychiatric medications classified by their pharmacology and mode of action. The NbN is updated yearly, equipping clinicians with the latest insights in neuroscience in a way that can be applied to their treatment of patients on a daily basis. To move from a disease-based classification

(e.g

PROGRAMME SPOTLIGHT: INTERVIEW WITH RAY DOLAN ON HOW WE Ray Dolan is the Mary Kinross Professor of Neuropsychiatry and Director of the Max Planck-UCL Centre for Computational Psychiatry and Ageing. He is a Fellow of the Royal Society (FRS).

OUTPUT - ECNP

Output. During the year, the ADHD across the Lifespan Network organises meetings for its members (also at the annual ECNP Congress). The Network has established a collaborative database of ADHD samples for research and of common protocols for data acquisition. It is currently preparing an internet-based testing battery to homogenize

and enrich

ECNP INDUSTRY MANUAL ECNP Industry Manual 34th ECNP Congress Hybrid, 2-5 October 2021, Lisbon, Portugal 4 The legal entity organising the congress is Stichting 34th ECNP Congress, hereafter called ECNP, a foundation incorporated under Dutch law, registered office Daltonlaan 400, 3584

BK Utrecht, The

ECNPCONGRESSESNEW FRONTIERS IN DIGITAL HEALTHSCHOOLSSEMINARSWORKSHOP NEUROPSYCHOPHARMACOLOGY ECNP is an independent scientific association dedicated to the science and treatment of disorders of the brain. It is the largest non-institutional supporter of applied and translational neuroscience research and education in Europe. 34TH ECNP CONGRESS HYBRID, 2-5 OCTOBER 2021, LISBON The ECNP Congress is Europe’s largest meeting in applied and translational neuroscience. Annually it brings together between 4,000 and 6,000 psychiatrists, neuroscientists, neurologists and psychologists from around the world to discuss the latest developments in the science and treatment of disorders of the brain. 35TH ECNP CONGRESS HYBRID, 15-18 OCTOBER 2022, VIENNA The ECNP Congress is Europe’s largest meeting in applied and translational neuroscience. Annually it brings together between 4,000 and 6,000 psychiatrists, neuroscientists, neurologists and psychologists from around the world to discuss the latest developments

in the

ECNP SCHOOL OF NEUROPSYCHOPHARMACOLOGY VIRTUAL ECNP has taken the decision to go virtual with the ECNP School of Neuropsychopharmacology in June 2021. This means that there will be no meeting in Oxford, and all content will be delivered online via required pre-recorded lectures from Friday 25 June to Tuesday 29 June 2021 and live sessions with faculty and peers from Wednesday 30 June

to

ABSTRACT SUBMISSION FOR POSTER PRESENTERS Abstract submission for poster presenters. It is no longer possible to submit your abstract. The deadline was 18 May 2021. It was also possible to submit a non-standard abstract.For example clinical cases, literature reviews and research proposals. ECNP SCHOOL OF CHILD AND

ADOLESCENT

ECNP took the decision to go virtual with the ECNP School of Child and Adolescent Neuropsychopharmacology in March 2021. This means that there was no meeting in Venice, and all content was delivered online via pre-recorded lectures from Friday 19 March to Tuesday 23 March 2021 and live sessions with faculty and peers from Wednesday 24 March

to

REGISTRATION

Registration. The 34th ECNP Congress 2021 is hybrid! Now you can join us in-person in Lisbon, Portugal, or follow the livestreamed congress programme online. Before entering the Registration Portal you will be asked to either login with your personal My ECNP account or create your ECNP account first. Group registration works on a voucher base. MYASTHENIA GRAVIS: CO-MORBID PSYCHIATRIC DISORDERS AND USE c c Myasthenia Gravis: co-morbid psychiatric disorders and use of psychotropic medication C. Machado;L. Monteiro; B Almeida; C. Fragoeiro* Psychiatry Residents, Magalhães Lemos Hospital, Porto, Portugal Poster number . P.5.d.004 The authors declare no conflicts

ofinterest

ASSESSMENT OF IMPULSIVITY WITH SELF-REPORT SCALES AND ÇağrıÖğüt1, Koray Başar1. 1Hacettepe University Faculty of Medicine, Department of Psychiatry, Ankara, Turkey. kbasar@hacettepe.edu.tr INTRODUCTION Impulsivity is a multidimentional construct involving diverse neuropsychological and neurobiological

processes.

ADDICTION IS A BRAIN DISEASE, AND IT MATTERS ALAN I DOI: 10.1126/science.278.5335.45 Science 278, 45 (1997); Alan I. Leshner Addiction Is a Brain Disease, and It Matters This copy is for your personal, non-commercial use only. ECNPCONGRESSESNEW FRONTIERS IN DIGITAL HEALTHSCHOOLSSEMINARSWORKSHOP NEUROPSYCHOPHARMACOLOGY ECNP is an independent scientific association dedicated to the science and treatment of disorders of the brain. It is the largest non-institutional supporter of applied and translational neuroscience research and education in Europe. 34TH ECNP CONGRESS HYBRID, 2-5 OCTOBER 2021, LISBON The ECNP Congress is Europe’s largest meeting in applied and translational neuroscience. Annually it brings together between 4,000 and 6,000 psychiatrists, neuroscientists, neurologists and psychologists from around the world to discuss the latest developments in the science and treatment of disorders of the brain. 35TH ECNP CONGRESS HYBRID, 15-18 OCTOBER 2022, VIENNA The ECNP Congress is Europe’s largest meeting in applied and translational neuroscience. Annually it brings together between 4,000 and 6,000 psychiatrists, neuroscientists, neurologists and psychologists from around the world to discuss the latest developments

in the

ECNP SCHOOL OF NEUROPSYCHOPHARMACOLOGY VIRTUAL ECNP has taken the decision to go virtual with the ECNP School of Neuropsychopharmacology in June 2021. This means that there will be no meeting in Oxford, and all content will be delivered online via required pre-recorded lectures from Friday 25 June to Tuesday 29 June 2021 and live sessions with faculty and peers from Wednesday 30 June

to

ABSTRACT SUBMISSION FOR POSTER PRESENTERS Abstract submission for poster presenters. It is no longer possible to submit your abstract. The deadline was 18 May 2021. It was also possible to submit a non-standard abstract.For example clinical cases, literature reviews and research proposals. ECNP SCHOOL OF CHILD AND

ADOLESCENT

ECNP took the decision to go virtual with the ECNP School of Child and Adolescent Neuropsychopharmacology in March 2021. This means that there was no meeting in Venice, and all content was delivered online via pre-recorded lectures from Friday 19 March to Tuesday 23 March 2021 and live sessions with faculty and peers from Wednesday 24 March

to

REGISTRATION

Registration. The 34th ECNP Congress 2021 is hybrid! Now you can join us in-person in Lisbon, Portugal, or follow the livestreamed congress programme online. Before entering the Registration Portal you will be asked to either login with your personal My ECNP account or create your ECNP account first. Group registration works on a voucher base. MYASTHENIA GRAVIS: CO-MORBID PSYCHIATRIC DISORDERS AND USE c c Myasthenia Gravis: co-morbid psychiatric disorders and use of psychotropic medication C. Machado;L. Monteiro; B Almeida; C. Fragoeiro* Psychiatry Residents, Magalhães Lemos Hospital, Porto, Portugal Poster number . P.5.d.004 The authors declare no conflicts

ofinterest

ASSESSMENT OF IMPULSIVITY WITH SELF-REPORT SCALES AND ÇağrıÖğüt1, Koray Başar1. 1Hacettepe University Faculty of Medicine, Department of Psychiatry, Ankara, Turkey. kbasar@hacettepe.edu.tr INTRODUCTION Impulsivity is a multidimentional construct involving diverse neuropsychological and neurobiological

processes.

ADDICTION IS A BRAIN DISEASE, AND IT MATTERS ALAN I DOI: 10.1126/science.278.5335.45 Science 278, 45 (1997); Alan I. Leshner Addiction Is a Brain Disease, and It Matters This copy is for your personal, non-commercial use only. THE HYBRID FORMAT AND WHAT IT MEANS FOR YOU For those who are able to join us in-person Lisbon, the hybrid format will allow you to: Participate in the full range of scientific sessions and symposia. Interact face-to-face with speakers, clinical experts and research leaders. Participate actively in ‘Love your

brain’,

ECNP SCHOOL OF CHILD AND

ADOLESCENT

ECNP took the decision to go virtual with the ECNP School of Child and Adolescent Neuropsychopharmacology in March 2021. This means that there was no meeting in Venice, and all content was delivered online via pre-recorded lectures from Friday 19 March to Tuesday 23 March 2021 and live sessions with faculty and peers from Wednesday 24 March

to

AGENDA - ECNP

ECNP Workshop for Early Career Scientists in Europe, Nice, France. 20-21 March. ECNP New Frontiers Meeting, Nice, France. 27 March - 1 April. ECNP School of Child and Adolescent Neuropsychopharmacology, Venice, Italy. 26 June - 1 July. ECNP School of Neuropsychopharmacology, Oxford, United Kingdom. 15-18 October.

ECNP SCHOOLS

The ECNP Schools have been established to encourage excellence in future leaders in clinical neuropsychopharmacology by propagating best practices during a week-long course, in that way contributing to the continuing improvement of the field’s high standards of practice. Per ECNP School, a maximum of 50 early career psychiatrists are

accepted. 1.

NEUROSCIENCE-BASED NOMENCLATURE (NBN) The NbN is a publication and a digital application of psychiatric medications classified by their pharmacology and mode of action. The NbN is updated yearly, equipping clinicians with the latest insights in neuroscience in a way that can be applied to their treatment of patients on a daily basis. To move from a disease-based classification

(e.g

ECNP INDUSTRY MANUAL ECNP Industry Manual 34th ECNP Congress Hybrid, 2-5 October 2021, Lisbon, Portugal 4 The legal entity organising the congress is Stichting 34th ECNP Congress, hereafter called ECNP, a foundation incorporated under Dutch law, registered office Daltonlaan 400, 3584

BK Utrecht, The

PRISM PROJECT AWARDED €16.5M IMI GRANT. INTERVIEW WITH ECNP Experimental Medicine Network spearheads €16.5m IMI grant A major European project to unpick the biological reasons underlying social withdrawal, led by ECNP’s Experimental Medicine Network, has been awarded €16.5m from the Innovative Medicine’s Initiative. BRAIN FOOD, THE NEUROBIOLOGY OF APPETITE AND ADDICTION A leading figure in the neurobiology of appetite, her work has particular focus on how food intake and feeding behaviour is controlled. Much of her emphasis is on the effect of endocrine and metabolic signals, chiefly ghrelin – a gastrointestinal hormone recognised as having a major influence on energy balance. “Obesity is a brain disorder. DEVELOPMENT OF THE IMMUNE STATUS QUESTIONNAIRE (ISQ) Development of the Immune Status Questionnaire (ISQ) References Donners, A.A.M.T., Tromp, M.D.P., Garssen, J., Roth, T., Verster,

J.C., 2015.

ADDICTION IS A BRAIN DISEASE, AND IT MATTERS ALAN I DOI: 10.1126/science.278.5335.45 Science 278, 45 (1997); Alan I. Leshner Addiction Is a Brain Disease, and It Matters This copy is for your personal, non-commercial use only. 34TH ECNP CONGRESS HYBRID, 2-5 OCTOBER 2021, LISBON The ECNP Congress is Europe’s largest meeting in applied and translational neuroscience. Annually it brings together between 4,000 and 6,000 psychiatrists, neuroscientists, neurologists and psychologists from around the world to discuss the latest developments in the science and treatment of disorders of the brain.

ECNP

ECNP is an independent scientific association dedicated to the science and treatment of disorders of the brain. It is the largest non-institutional supporter of applied and translational neuroscience research and education in Europe. 35TH ECNP CONGRESS HYBRID, 15-18 OCTOBER 2022, VIENNA The ECNP Congress is Europe’s largest meeting in applied and translational neuroscience. Annually it brings together between 4,000 and 6,000 psychiatrists, neuroscientists, neurologists and psychologists from around the world to discuss the latest developments

in the

ECNP SCHOOL OF NEUROPSYCHOPHARMACOLOGY VIRTUAL ECNP has taken the decision to go virtual with the ECNP School of Neuropsychopharmacology in June 2021. This means that there will be no meeting in Oxford, and all content will be delivered online via required pre-recorded lectures from Friday 25 June to Tuesday 29 June 2021 and live sessions with faculty and peers from Wednesday 30 June

to

REGISTRATION

Registration. The 34th ECNP Congress 2021 is hybrid! Now you can join us in-person in Lisbon, Portugal, or follow the livestreamed congress programme online. Before entering the Registration Portal you will be asked to either login with your personal My ECNP account or create your ECNP account first. Group registration works on a voucher base. ABSTRACT SUBMISSION FOR POSTER PRESENTERS Abstract submission for poster presenters. It is no longer possible to submit your abstract. The deadline was 18 May 2021. It was also possible to submit a non-standard abstract.For example clinical cases, literature reviews and research proposals. NEUROSCIENCE-BASED NOMENCLATURE (NBN) The NbN is a publication and a digital application of psychiatric medications classified by their pharmacology and mode of action. The NbN is updated yearly, equipping clinicians with the latest insights in neuroscience in a way that can be applied to their treatment of patients on a daily basis. To move from a disease-based classification

(e.g

A CASE-BASED APPROACH TO EARLY INTERVENTION IN SCHIZOPHRENIA 3 TARGET AUDIENCE This activity is intended for an international audience of non-US psychiatrists, and neurologists. LEARNING OBJECTIVES Upon completion of this activity, participants will: MYASTHENIA GRAVIS: CO-MORBID PSYCHIATRIC DISORDERS AND USE c c Myasthenia Gravis: co-morbid psychiatric disorders and use of psychotropic medication C. Machado;L. Monteiro; B Almeida; C. Fragoeiro* Psychiatry Residents, Magalhães Lemos Hospital, Porto, Portugal Poster number . P.5.d.004 The authors declare no conflicts

ofinterest

ASSESSMENT OF IMPULSIVITY WITH SELF-REPORT SCALES AND ÇağrıÖğüt1, Koray Başar1. 1Hacettepe University Faculty of Medicine, Department of Psychiatry, Ankara, Turkey. kbasar@hacettepe.edu.tr INTRODUCTION Impulsivity is a multidimentional construct involving diverse neuropsychological and neurobiological

processes.

34TH ECNP CONGRESS HYBRID, 2-5 OCTOBER 2021, LISBON The ECNP Congress is Europe’s largest meeting in applied and translational neuroscience. Annually it brings together between 4,000 and 6,000 psychiatrists, neuroscientists, neurologists and psychologists from around the world to discuss the latest developments in the science and treatment of disorders of the brain.

ECNP

ECNP is an independent scientific association dedicated to the science and treatment of disorders of the brain. It is the largest non-institutional supporter of applied and translational neuroscience research and education in Europe. 35TH ECNP CONGRESS HYBRID, 15-18 OCTOBER 2022, VIENNA The ECNP Congress is Europe’s largest meeting in applied and translational neuroscience. Annually it brings together between 4,000 and 6,000 psychiatrists, neuroscientists, neurologists and psychologists from around the world to discuss the latest developments

in the

ECNP SCHOOL OF NEUROPSYCHOPHARMACOLOGY VIRTUAL ECNP has taken the decision to go virtual with the ECNP School of Neuropsychopharmacology in June 2021. This means that there will be no meeting in Oxford, and all content will be delivered online via required pre-recorded lectures from Friday 25 June to Tuesday 29 June 2021 and live sessions with faculty and peers from Wednesday 30 June

to

REGISTRATION

Registration. The 34th ECNP Congress 2021 is hybrid! Now you can join us in-person in Lisbon, Portugal, or follow the livestreamed congress programme online. Before entering the Registration Portal you will be asked to either login with your personal My ECNP account or create your ECNP account first. Group registration works on a voucher base. ABSTRACT SUBMISSION FOR POSTER PRESENTERS Abstract submission for poster presenters. It is no longer possible to submit your abstract. The deadline was 18 May 2021. It was also possible to submit a non-standard abstract.For example clinical cases, literature reviews and research proposals. NEUROSCIENCE-BASED NOMENCLATURE (NBN) The NbN is a publication and a digital application of psychiatric medications classified by their pharmacology and mode of action. The NbN is updated yearly, equipping clinicians with the latest insights in neuroscience in a way that can be applied to their treatment of patients on a daily basis. To move from a disease-based classification

(e.g

A CASE-BASED APPROACH TO EARLY INTERVENTION IN SCHIZOPHRENIA 3 TARGET AUDIENCE This activity is intended for an international audience of non-US psychiatrists, and neurologists. LEARNING OBJECTIVES Upon completion of this activity, participants will: MYASTHENIA GRAVIS: CO-MORBID PSYCHIATRIC DISORDERS AND USE c c Myasthenia Gravis: co-morbid psychiatric disorders and use of psychotropic medication C. Machado;L. Monteiro; B Almeida; C. Fragoeiro* Psychiatry Residents, Magalhães Lemos Hospital, Porto, Portugal Poster number . P.5.d.004 The authors declare no conflicts

ofinterest

ASSESSMENT OF IMPULSIVITY WITH SELF-REPORT SCALES AND ÇağrıÖğüt1, Koray Başar1. 1Hacettepe University Faculty of Medicine, Department of Psychiatry, Ankara, Turkey. kbasar@hacettepe.edu.tr INTRODUCTION Impulsivity is a multidimentional construct involving diverse neuropsychological and neurobiological

processes.

ECNP CONGRESSES

ECNP Congresses 34 th ECNP Congress Hybrid, 2-5 October 2021, Lisbon, Portugal The annual ECNP Congress is Europe’s largest meeting in applied and translational neuroscience. Held every autumn, the ECNP Congress brings together psychiatrists, neuroscientists, neurologists and psychologists from around the world to discuss the latest developments in the science and treatment of brain disorders. THE HYBRID FORMAT AND WHAT IT MEANS FOR YOU For those who are able to join us in-person Lisbon, the hybrid format will allow you to: Participate in the full range of scientific sessions and symposia. Interact face-to-face with speakers, clinical experts and research leaders. Participate actively in ‘Love your

brain’,

THE ECNP OFFICE

The ECNP Office The ECNP Office is charged with supporting the Executive Committee and implementing its directives. It coordinates member activities and administers, organises and publishes all ECNP’s programmes, initiatives and resources, as well as serving as the central contact point for information about and communication with

ECNP.

AGENDA - ECNP

ECNP Workshop for Early Career Scientists in Europe, Nice, France. 20-21 March. ECNP New Frontiers Meeting, Nice, France. 27 March - 1 April. ECNP School of Child and Adolescent Neuropsychopharmacology, Venice, Italy. 26 June - 1 July. ECNP School of Neuropsychopharmacology, Oxford, United Kingdom. 15-18 October. ECNP SCHOOL OF CHILD AND

ADOLESCENT

ECNP took the decision to go virtual with the ECNP School of Child and Adolescent Neuropsychopharmacology in March 2021. This means that there was no meeting in Venice, and all content was delivered online via pre-recorded lectures from Friday 19 March to Tuesday 23 March 2021 and live sessions with faculty and peers from Wednesday 24 March

to

ECNP SCHOOLS

The ECNP Schools have been established to encourage excellence in future leaders in clinical neuropsychopharmacology by propagating best practices during a week-long course, in that way contributing to the continuing improvement of the field’s high standards of practice. Per ECNP School, a maximum of 50 early career psychiatrists are

accepted. 1.

NEUROSCIENCE-BASED NOMENCLATURE (NBN) The NbN is a publication and a digital application of psychiatric medications classified by their pharmacology and mode of action. The NbN is updated yearly, equipping clinicians with the latest insights in neuroscience in a way that can be applied to their treatment of patients on a daily basis. To move from a disease-based classification

(e.g

ECNP INDUSTRY MANUAL ECNP Industry Manual 34th ECNP Congress Hybrid, 2-5 October 2021, Lisbon, Portugal 4 The legal entity organising the congress is Stichting 34th ECNP Congress, hereafter called ECNP, a foundation incorporated under Dutch law, registered office Daltonlaan 400, 3584

BK Utrecht, The

PRISM PROJECT AWARDED €16.5M IMI GRANT. INTERVIEW WITH ECNP Experimental Medicine Network spearheads €16.5m IMI grant A major European project to unpick the biological reasons underlying social withdrawal, led by ECNP’s Experimental Medicine Network, has been awarded €16.5m from the Innovative Medicine’s Initiative. ADDICTION IS A BRAIN DISEASE, AND IT MATTERS ALAN I DOI: 10.1126/science.278.5335.45 Science 278, 45 (1997); Alan I. Leshner Addiction Is a Brain Disease, and It Matters This copy is for your personal, non-commercial use only.

Cookie Policy

Our website uses functional and analytics cookies to tailor our services and website to your needs. With your consent, our website also uses tracking cookies for marketing purposes. For more information about the use of cookies, please read our cookies policy . Please note that you can change your cookie options at any time via your browser settings. Read more I do not accept tracking cookiesI accept tracking cookies

.

2021 ECNP Congress

__

* Events

* Congresses

* Past congresses

* New Frontiers in Digital Health

* Schools

* Seminars

* Workshop Neuropsychopharmacology * Workshop Clinical Research Methods * Research & Innovation

* Awards

* Journal

* ECNP Networks

* Neuroscience-based Nomenclature (NbN) * New Frontiers in Digital Health Meeting Virtual * Supporting European proposals * ECNP Medicines Chest

* Early Career

* Definition Early Career Scientist

* Schools

* Seminars

* Workshop Neuropsychopharmacology Virtual * Workshop Clinical Research Methods Virtual * Mentorship Programme * Research Internship

* Awards

* Job postings

* Early Career Advisory Panel

* News

* ECNP corona watch

* Agenda

* Newsletters

* President's blog

* Webcasts

* ECNP in depth: interviews

* Expert Talks

* Reports

* Press office

* About

* Our aims and objectives * How we are organised

* Membership

* Governance

* ECNP history

* My ECNP

* My ECNP

* Members website

*

*

*

YOU HAVE TIME TO APPLY UNTIL 1 DECEMBER! Dedicated to the role of digital medicine in therapy development for brain disorders, this meeting will be held virtually on 8 and 9

March.Apply now __

SUBMIT YOUR ABSTRACT BY 1 DECEMBER! This online workshop (3-5 March 2021) is for Early Career Scientists interested in pursuing a research career in neuropsychopharmacology.Submit now __ ACCESS ECNP CONGRESS CONTENT UNTIL 15 DECEMBER If you are a registered delegate of the 33rd ECNP Congress Virtual, you can access all content on demand for three months! Enter here __

ABOUT ECNP

ECNP is an independent scientific association dedicated to the science and treatment of disorders of the brain. It is the largest non-institutional supporter of applied and translational neuroscience research and education in Europe. Read more...

ECNP MEMBERSHIP

ECNP offers membership to established scholars in the field and all those with an active interest in applied and translational neuroscience. Corresponding membership is also open for those not resident in Europe.  To our membership pages

FUTURE MEETINGS

ECNP organises a wide range of scientific and educational activities, programmes and events across Europe, promoting the exchange of high-quality experimental and clinical research in applied and translational neuroscience and fostering young scientists and clinicians. View agenda

CORONAVIRUS NEWS

In response to the unprecedented impact of the coronavirus ECNP is progressively redesigning all its programmes and events to protect participant safety and support global corona containment efforts. All face-to-face meetings up until summer 2021 have either been suspended or transitioned to virtual platforms. Read more

.

For the ECNP corona file of video commentary and best practices from experts within the ECNP community, visit this page

.

NEWS

34TH ECNP CONGRESS: A NEW PLENARY LECTURE CONFIRMED Carmen Sandi, Switzerland is a world leader in the field that connects stress with brain function and behaviour. Her laboratory adopts an integrative research program in rodents and humans, and places a strong emphasis on understanding the neurobiology of individual differences. A current strong focus of her studies is on the role of mitochondria and metabolism in brain, behaviour and psychopathology.

Read more

------------------------- WHAT IS THE C4C PROJECT? The conect4children (c4c) project, a major IMI-funded initiative launched to take Europe’s clinical trial infrastructure for children to the next level, facilitating quicker and more efficient drug development for paediatric diseases, is already making its mark.

Read more

------------------------- LAST ISSUE OF THE ECNP NEWSLETTER Many interesting topics in this month’s ECNP newsletter: abstract submission for the ECNP Workshop for Early Career Scientists in Europe Virtual, application still open for the New Frontiers in Digital Health Meeting Virtual, four Plenary Lectures confirmed for the 34th ECNP Congress and much more... Read the full e-news here

DEADLINES

1 DECEMBER 2020

ABSTRACT SUBMISSION FOR ECNP WORKSHOP FOR EARLY CAREER SCIENTISTS IN

EUROPE VIRTUAL

If you wish to attend the workshop, submit your scientific abstract. APPLICATION ECNP NEW FRONTIERS IN DIGITAL HEALTH MEETING 2021 All representatives from IT, pharma and medical devices industry, regulators, and patient and family associations are invited to apply!

15 DECEMBER 2020

CME ACCREDITATION

The programme of the 33rd ECNP Congress Virtual is accordingly fully accredited by the relevant accrediting agencies for European and US CME credits. Apply online to receive your accreditation credits! ECNP NETWORKS AND TWGS ECNP Networks foster collaboration among experts interested in specific brain-research topics. As well as the Networks themselves, ECNP has also instituted Thematic Working Groups (TWGs) as a way to stimulate new Networks activities, encourage collaboration and facilitate the Networks mission. To discover more, click here . EXPERIENCE THE ECNP CONGRESS! Take a tour of Europe's global event dedicated to innovation in the treatment of brain disorders!

EVENTS

* Congresses

* Past congresses

* New Frontiers in Digital Health

* Schools

* Seminars

* Workshop Neuropsychopharmacology * Workshop Clinical Research Methods RESEARCH & INNOVATION

* Awards

* Journal

* ECNP Networks

* Neuroscience-based Nomenclature (NbN) * New Frontiers in Digital Health Meeting Virtual * Supporting European proposals * ECNP Medicines Chest

EARLY CAREER

* Definition Early Career Scientist

* Schools

* Seminars

* Workshop Neuropsychopharmacology Virtual * Workshop Clinical Research Methods Virtual * Mentorship Programme * Research Internship

* Awards

* Job postings

* Early Career Advisory Panel

NEWS

* ECNP corona watch

* Agenda

* Newsletters

* President's blog

* Webcasts

* ECNP in depth: interviews

* Expert Talks

* Reports

* Press office

ABOUT

* Our aims and objectives * How we are organised

* Membership

* Governance

* ECNP history

MY ECNP

* My ECNP

* Members website

SECRETARIAT

ECNP Office

T: +31 85 7826 670

E: secretariat@ecnp.eu

www.ecnp.eu

www.ecnp.eu/Congress2020 www.ecnp.eu/Congress2021

ADDRESS

* Daltonlaan 400

* 3584 BK Utrecht

* The Netherlands

The ECNP Office, due to the current situation, is working from

home.

You can reach us via email.

* __

* __

* __

* __

DISCLAIMERS

DISCLAIMERS

ABOUT

ECNP is a public-interest-serving entity Privacy and data security policy � ECNP 2020 | All rights reserved | Disclaimers |

About